简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-05-24 14:15 ReNAgade Therapeutics Launches with over $300 Million in Series A Financing To Unlock the Limitless Potential of RNA Medicine
2023-05-23 16:21 Exscientia Highlights "The Future of AI-enabled Drug Discovery" at SLAS Europe
2023-05-23 14:49 HiST Pharma Announces U.S. FDA Approval to Initiate Phase III Clinical Study With TC Cream – World’s First Botanical Small-Molecule Drug That Treats Psoriasis Vulgaris
2023-05-18 16:07 Alliance Pharma and Drug Development Solutions Are Now Resolian
2023-05-18 13:56 Exscientia to Report First Quarter 2023 Financial Results on May 24, 2023
2023-05-17 15:42 Carbios Recognized as a Flagship Start-up in French Green Innovation at the Choose France Summit
2023-05-17 13:28 Parse Biosciences Expands Global Access to Israel
2023-05-16 18:45 AOP Health congratulates FROM on its great scientific work in the field of myeloproliferative neoplasms
2023-05-16 17:06 UK’s Nurse Margaret Wins the Coveted Aster Guardians Global Nursing Award 2023
2023-05-16 12:55 Exscientia Announces Sixth Molecule Created Through Generative AI Platform to Enter Clinical Stage
2023-05-12 20:03 AOP Health Presents New Findings Regarding Consistent Hematologic Response of Patients With polycythaemia vera
2023-05-12 15:06 Nagasaki University Presented Results Of a Specified Clinical Trial On The Use of L. lactis strain Plasma For Patients With COVID-19
2023-05-10 18:02 Four Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, Presented at DDW 2023
2023-05-10 16:21 Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight
2023-05-10 08:36 Boehringer Ingelheim Begins Clinical Development of First-In-Class Treatment for Fibrotic Diseases
2023-05-09 15:31 Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor
2023-05-09 11:27 Cambridge University Hospitals Expands Virtual Care Program with Masimo W1™
2023-05-05 11:39 Kenvue to Begin Trading on the New York Stock Exchange
2023-05-05 10:36 Aquyre Biosciences Announces Appointment of F. Samuel Eberts III as CEO and Chairman of the Board of Directors & Founder Bertrand de Poly as Chief Strategy & Technology Officer
2023-05-04 17:20 Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors

Business Wire Weibo

Press Releases

Latest Releases